SCHEMBL14760960

SCHEMBL14760960

CCCCCCCC(=O)OCCCl

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.77
DNM1 Q05193 1/20 0.62
PAM P19021 2/20 0.58
TSHR P16473 1/20 0.55
MAPT P10636 1/20 0.55
PRSS1 P07477 1/20 0.54
PRSS2 P07478 1/20 0.54
PRSS3 P35030 1/20 0.54
NAAA Q02083 1/20 0.53
LMNA P02545 4/20 0.53
ALDH1A1 P00352 1/20 0.53
KDM4E B2RXH2 1/20 0.51
DUSP3 P51452 1/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
HTR2C P28335 1/20 0.51
PRKCA P17252 1/20 0.49
PRKCE Q02156 1/20 0.49
PRKCQ Q04759 1/20 0.49
PRKCD Q05655 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4362110 1.00 DGKA (0.77) DGKADNM1PAMTSHRMAPT
SCHEMBL10430876 1.00 DGKA (0.77) DGKADNM1PAMTSHRMAPT
SCHEMBL5318935 1.00 DGKA (0.77) DGKADNM1PAMTSHRMAPT
SCHEMBL5319219 1.00 DGKA (0.77) DGKADNM1PAMTSHRMAPT
SCHEMBL11794989 1.00 DGKA (0.77) DGKADNM1PAMTSHRMAPT
SCHEMBL9948675 1.00 DGKA (0.77) DGKADNM1PAMTSHRMAPT
SCHEMBL11785899 0.98 DGKA (0.73) DGKADNM1PAMTSHRMAPT
Dimethylamine SCHEMBL20566068 0.94 DGKA (0.69) DGKADNM1PAMTSHRMAPT
SCHEMBL11791883 0.92 DGKA (0.63) DGKADNM1PAMTSHRMAPT
SCHEMBL11782881 0.90 DGKA (0.62) DGKAMAPTLMNAALDH1A1DUSP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114058173-A Process and composition for producing flexible polyurethane foams 赢创运营有限公司 2022-02-18 CN claimed
CN-122070276-A Prodrugs of xanomeline, prodrugs of trospium chloride and methods of using the same 人类生物科学股份有限公司 2026-05-19 CN disclosed
EP-4705289-A1 PRODRUGS OF XANOMELINE, PRODRUGS OF TROSPIUM AND METHODS OF USE THEREOF Terran Biosciences Inc. (US) 2026-03-11 EP disclosed
WO-2024226691-A1 PRODRUGS OF XANOMELINE, PRODRUGS OF TROSPIUM AND METHODS OF USE THEREOF TERRAN BIOSCIENCES INC. (US) 2024-10-31 WO disclosed
US-9067845-B2 Process for hydrochlorination of multihydroxylated aliphatic hydrocarbons DOW GLOBAL TECHNOLOGIES LLC (US) 2015-06-30 US disclosed
US-20130066091-A1 PROCESS FOR HYDROCHLORINATION OF MULTIHYDROXYLATED ALIPHATIC HYDROCARBONS DOW GLOBAL TECHNOLOGIES LLC (US) 2013-03-14 US disclosed
CN-102918015-A Process for hydrochlorination of multihydroxylated aliphatic hydrocarbons DOW GLOBAL TECHNOLOGIES LLC 2013-02-06 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130066091-A1 PROCESS FOR HYDROCHLORINATION OF MULTIHYDROXYLATED ALIPHATIC HYDROCARBONS HDHD5, HRH3, HRH1 DGKA 1311/4885DNM1 2063/4885PAM 271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.